BioVie signs at-the-market equity sales agreement for up to $6.46 million Class A shares
BIVI•Commission and proceeds
A.G.P. will receive a 3% commission on gross proceeds. BioVie will also reimburse certain agent expenses.
Proceeds are earmarked for general corporate purposes.
Termination of the program
The program ends once the full amount is sold, the shelf registration expires, or either party terminates the agreement.
At-the-market sales agreement
BioVie entered an at-the-market sales agreement with A.G.P./Alliance Global Partners to sell up to $6.46 million of Class A common stock.
Shares may be sold from time to time on Nasdaq or in negotiated transactions, with sales paced to market conditions.
